Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/FJC.0000000000001629 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Sodium-glucose co-transporter-2 inhibitors: A paradigm shift in treatment for type 2 diabetes.
Diabetes Obes Metab
October 2024
Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK.
Editorial on: Canagliflozin Mediates Mitophagy Through the AMPK/PINK1/PARKIN Pathway to Alleviate Isoprenaline-Induced Cardiac Remodeling.
J Cardiovasc Pharmacol
November 2024
Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, IT.
SGLT2 inhibitors: not every drug has the same effect.
Am J Physiol Renal Physiol
June 2024
Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida, United States.
CHIEF Effects of Sodium Glucose Co-Transporter Inhibitors on Health-Related Quality of Life in Heart Failure.
JACC Heart Fail
April 2024
University of Colorado, School of Medicine, Aurora, Colorado, USA. Electronic address:
Advancing the fight against fibrosis in patients with heart failure: The contribution of sodium-glucose cotransporter 2 inhibition.
Eur J Heart Fail
February 2024
Center for Applied Medical Research (CIMA), and School of Medicine, University of Navarra, Pamplona, Spain.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!